Log in to save to my catalogue

bmj-2022-072175.R1Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive,...

bmj-2022-072175.R1Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive,...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9667467

bmj-2022-072175.R1Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial

Publication information

Publisher

BMJ Publishing Group Ltd

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9667467

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9667467

Other Identifiers

ISSN

0959-8138

E-ISSN

1756-1833

DOI

10.1136/bmj-2022-072175

How to access this item